Share ownership IXICO plc

IXI

GB00BFXR4C20

Biotechnology & Medical Research

Market Closed - London S.E. Other stock markets 11:35:26 2025-12-15 EST			5-day change	1st Jan Change
11.75 ^GBX	-4.08%		+9.30%	-

12-10	IXICO plc, 2025 Earnings Call, Dec 09, 2025
12-09	EARNINGS AND TRADING: Great Southern widens loss; MediaZest revenue up	AN

Share class: IXICO plc

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	92,668,598	64,306,218 ( 69.39 %)	0	69.39 %

Major shareholders: IXICO plc

Name	Equities	%	Valuation
Gresham House Asset Management Ltd. 17.2 %	15,938,925	17.2 %	2 M p
BGF Investment Management Ltd. 13.91 %	12,887,000	13.91 %	2 M p
Octopus Investments Ltd. 10.11 %	9,366,062	10.11 %	1 M p
Maven Capital Partners UK LLP 8.721 %	8,081,651	8.721 %	1 M p
Canaccord Genuity Asset Management Ltd. 8.062 %	7,471,000	8.062 %	1 M p
Canaccord Genuity Wealth Ltd. 7.822 %	7,248,272	7.822 %	1 M p
Riverrock Capital Ltd. (United Kingdom) 4.163 %	3,857,566	4.163 %	562 240 p
Unicorn Asset Management Ltd. 3.87 %	3,586,000	3.87 %	522 660 p
Hargreaves Lansdown Asset Management Ltd. 2.744 %	2,543,000	2.744 %	370 642 p
City Asset Management Plc 1.541 %	1,427,860	1.541 %	208 111 p
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Breakdown by shareholder type

Institutional	80.33%
Individuals	0.92%
Other	0.16%
Unknown	18.59%

Based on 1000 largest holdings

Geographical origin of shareholders

United Kingdom	80.06%
Individuals	0.92%
United States	0.16%
Luxembourg	0.14%
Switzerland	0.1%
Netherlands	0.03%

Based on 1000 largest holdings

IXICO plc is a United Kingdom-based medical imaging advanced analytics company. The Company is engaged in delivering insights in neuroscience to help transform the advancement of investigational therapies for neurological diseases, such as Huntington's disease, Parkinson's disease and Alzheimer's disease. It advances medicine and human health by turning data into clinically meaningful information, providing new insights in neuroscience by supporting pharmaceutical companies across all phases of central nervous system (CNS) clinical research. Its services include the collection, analysis, management, and reporting on data generated in the course of a clinical study. Its data platforms include TrialTracker and Assessa. The TrialTracker platform provides a secure and compliant environment for the collection, analysis and interpretation of large image files and other data. Its neuroimaging biomarkers focus area includes Radiological Reads, Volumetric MRI, PET and SPECT, and Advanced MRI.

Employees

Sector

Biotechnology & Medical Research

Calendar

05-25 - Q2 2026 Earnings Release (Projected)

More about the company